1,326
Views
18
CrossRef citations to date
0
Altmetric
Research Article

The anti-angiogenic herbal extracts Ob-X from Morus alba, Melissa officinalis, and Artemisia capillaris suppresses adipogenesis in 3T3-L1 adipocytes

, &
Pages 775-783 | Received 19 Sep 2010, Accepted 08 Dec 2010, Published online: 31 Mar 2011

References

  • Armstrong LC, Bornstein P. (2003). Thrombospondins 1 and 2 function as inhibitors of angiogenesis. Matrix Biol, 22, 63–71.
  • Bikfalvi A, Klein S, Pintucci G, Rifkin DB. (1997). Biological roles of fibroblast growth factor-2. Endocr Rev, 18, 26–45.
  • Bouloumié A, Lolmède K, Sengenès C, Galitzky J, Lafontan M. (2002). Angiogenesis in adipose tissue. Ann Endocrinol (Paris), 63, 91–95.
  • Bouloumié A, Sengenès C, Portolan G, Galitzky J, Lafontan M. (2001). Adipocyte produces matrix metalloproteinases 2 and 9: involvement in adipose differentiation. Diabetes, 50, 2080–2086.
  • Bråkenhielm E, Cao R, Gao B, Angelin B, Cannon B, Parini P, Cao Y. (2004). Angiogenesis inhibitor, TNP-470, prevents diet-induced and genetic obesity in mice. Circ Res, 94, 1579–1588.
  • Cao Y. (2007). Angiogenesis modulates adipogenesis and obesity. J Clin Invest, 117, 2362–2368.
  • Cao Y. (2010). Adipose tissue angiogenesis as a therapeutic target for obesity and metabolic diseases. Nat Rev Drug Discov, 9, 107–115.
  • Carmeliet P, Ferreira V, Breier G, Pollefeyt S, Kieckens L, Gertsenstein M, Fahrig M, Vandenhoeck A, Harpal K, Eberhardt C, Declercq C, Pawling J, Moons L, Collen D, Risau W, Nagy A. (1996). Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature, 380, 435–439.
  • Chavey C, Mari B, Monthouel MN, Bonnafous S, Anglard P, Van Obberghen E, Tartare-Deckert S. (2003). Matrix metalloproteinases are differentially expressed in adipose tissue during obesity and modulate adipocyte differentiation. J Biol Chem, 278, 11888–11896.
  • Christiaens V, Lijnen HR. (2006). Role of the fibrinolytic and matrix metalloproteinase systems in development of adipose tissue. Arch Physiol Biochem, 112, 254–259.
  • Claffey KP, Wilkison WO, Spiegelman BM. (1992). Vascular endothelial growth factor. Regulation by cell differentiation and activated second messenger pathways. J Biol Chem, 267, 16317–16322.
  • Couillard C, Mauriège P, Imbeault P, Prud’homme D, Nadeau A, Tremblay A, Bouchard C, Després JP. (2000). Hyperleptinemia is more closely associated with adipose cell hypertrophy than with adipose tissue hyperplasia. Int J Obes Relat Metab Disord, 24, 782–788.
  • Crandall DL, Hausman GJ, Kral JG. (1997). A review of the microcirculation of adipose tissue: Anatomic, metabolic, and angiogenic perspectives. Microcirculation, 4, 211–232.
  • Croissandeau G, Chrétien M, Mbikay M. (2002). Involvement of matrix metalloproteinases in the adipose conversion of 3T3-L1 preadipocytes. Biochem J, 364, 739–746.
  • Fajas L, Schoonjans K, Gelman L, Kim JB, Najib J, Martin G, Fruchart JC, Briggs M, Spiegelman BM, Auwerx J. (1999). Regulation of peroxisome proliferator-activated receptor gamma expression by adipocyte differentiation and determination factor 1/sterol regulatory element binding protein 1: implications for adipocyte differentiation and metabolism. Mol Cell Biol, 19, 5495–5503.
  • Fukumura D, Ushiyama A, Duda DG, Xu L, Tam J, Krishna V, Chatterjee K, Garkavtsev I, Jain RK. (2003). Paracrine regulation of angiogenesis and adipocyte differentiation during in vivo adipogenesis. Circ Res, 93, e88–e97.
  • Galardy RE, Grobelny D, Foellmer HG, Fernandez LA. (1994). Inhibition of angiogenesis by the matrix metalloprotease inhibitor N-[2R-2-(hydroxamidocarbonymethyl)-4-methylpentanoyl]-L-tryptophan methylamide. Cancer Res, 54, 4715–4718.
  • Kawaguchi N, Toriyama K, Nicodemou-Lena E, Inou K, Torii S, Kitagawa Y. (1998). De novo adipogenesis in mice at the site of injection of basement membrane and basic fibroblast growth factor. Proc Natl Acad Sci USA, 95, 1062–1066.
  • Kim MY, Park BY, Lee HS, Park EK, Hahm JC, Lee J, Hong Y, Choi S, Park D, Lee H, Yoon M. (2010). The anti-angiogenic herbal composition Ob-X inhibits adipose tissue growth in obese mice. Int J Obes (Lond), 34, 820–830.
  • Kim J, Park BY, Park EK, Lee HS, Halm JC, Bae KH, Kim MY. (2006): Screening of anti-angiogenic activity from plant extracts. Kor J Pharmacogn, 37, 253–257.
  • Lee J, Chae K, Ha J, Park BY, Lee HS, Jeong S, Kim MY, Yoon M. (2008). Regulation of obesity and lipid disorders by herbal extracts from Morus alba, Melissa officinalis, and Artemisia capillaris in high-fat diet-induced obese mice. J Ethnopharmacol, 115, 263–270.
  • Lijnen HR. (2008). Angiogenesis and obesity. Cardiovasc Res, 78, 286–293.
  • Lijnen HR, Maquoi E, Hansen LB, Van Hoef B, Frederix L, Collen D. (2002). Matrix metalloproteinase inhibition impairs adipose tissue development in mice. Arterioscler Thromb Vasc Biol, 22, 374–379.
  • Maquoi E, Munaut C, Colige A, Collen D, Lijnen HR. (2002). Modulation of adipose tissue expression of murine matrix metalloproteinases and their tissue inhibitors with obesity. Diabetes, 51, 1093–1101.
  • Rosen ED, Sarraf P, Troy AE, Bradwin G, Moore K, Milstone DS, Spiegelman BM, Mortensen RM. (1999). PPAR gamma is required for the differentiation of adipose tissue in vivo and in vitro. Mol Cell, 4, 611–617.
  • Rosen ED, Spiegelman BM. (2000). Molecular regulation of adipogenesis. Annu Rev Cell Dev Biol, 16, 145–171.
  • Rupnick MA, Panigrahy D, Zhang CY, Dallabrida SM, Lowell BB, Langer R, Folkman MJ. (2002). Adipose tissue mass can be regulated through the vasculature. Proc Natl Acad Sci USA, 99, 10730–10735.
  • Sang QX. (1998). Complex role of matrix metalloproteinases in angiogenesis. Cell Res, 8, 171–177.
  • Silverman KJ, Lund DP, Zetter BR, Lainey LL, Shahood JA, Freiman DG, Folkman J, Barger AC. (1988). Angiogenic activity of adipose tissue. Biochem Biophys Res Commun, 153, 347–352.
  • Tam J, Duda DG, Perentes JY, Quadri RS, Fukumura D, Jain RK. (2009). Blockade of VEGFR2 and not VEGFR1 can limit diet-induced fat tissue expansion: role of local versus bone marrow-derived endothelial cells. Plos ONE, 4, e4974.
  • Voros G, Maquoi E, Demeulemeester D, Clerx N, Collen D, Lijnen HR. (2005). Modulation of angiogenesis during adipose tissue development in murine models of obesity. Endocrinology, 146, 4545–4554.
  • Wu Z, Bucher NL, Farmer SR. (1996). Induction of peroxisome proliferator-activated receptor gamma during the conversion of 3T3 fibroblasts into adipocytes is mediated by C/EBPbeta, C/EBPdelta, and glucocorticoids. Mol Cell Biol, 16, 4128–4136.
  • Yoon M, Kim MY (2010): The anti-angiogenic herbal composition Ob-X from Morus alba, Melissa officinalis, and Artemisia capillaris regulates obesity in genetically obese ob/ob mice. Pharm Biol (accepted)

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.